<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03106350</url>
  </required_header>
  <id_info>
    <org_study_id>13/2557</org_study_id>
    <nct_id>NCT03106350</nct_id>
  </id_info>
  <brief_title>Symptoms Experienced and Quality of Life in Breast Cancer Receiving Radiotherapy</brief_title>
  <official_title>Symptoms Experienced and Quality of Life in Patients With Breast Cancer Receiving Radiotherapy Across One Year</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chulabhorn Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chulabhorn Cancer Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      EORTC-QLQ-30 questionnaire filled in by participants 6 times
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      EORTC-QLQ-30 questionnaire filled in by participants 6 times

        -  1st before receive radiotherapy

        -  2nd after receive radiotherapy

        -  3th 1 month after receive radiotherapy

        -  4th 3 month after receive radiotherapy

        -  5th 6 month after receive radiotherapy

        -  6th 1 year after receive radiotherapy
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2015</start_date>
  <completion_date type="Actual">February 28, 2017</completion_date>
  <primary_completion_date type="Actual">February 28, 2017</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>symptoms experienced</measure>
    <time_frame>Change from Baseline symptoms experienced at 1 month,3 month,6 month,1 year after radiotherapy</time_frame>
    <description>symptoms experienced collected by EORTC-QLQ-30</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>quality of life</measure>
    <time_frame>Change from Baseline quality of life at 1 month,3 month,6 month,1 year after radiotherapy</time_frame>
    <description>quality of life collected by EORTC-QLQ-30</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">103</enrollment>
  <condition>Quality of Life</condition>
  <arm_group>
    <arm_group_label>questionnaire</arm_group_label>
    <description>EORTC-QLQ-30 questionnaire</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire</intervention_name>
    <description>The EORTC QLQ-C30 is a questionnaire developed to assess the quality of life of cancer patients. It is a copyrighted instrument, which has been translated and validated in over 100 languages and is used in more than 3,000 studies worldwide.</description>
    <arm_group_label>questionnaire</arm_group_label>
    <other_name>EORTC-QLQ-30 Questionnaire</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with breast cancer
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  good consciousness

          -  ability to understand and provide information

          -  no hearing impairment

          -  Eastern Cooperative Oncology Group performance level of 0 to 2

        Exclusion Criteria:

          -  prior radiotherapy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Saengrawee Thanthong, M.N.S</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chulabhorn Hospital</affiliation>
  </overall_official>
  <link>
    <url>http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx</url>
    <description>2.1. Globocan 2012: Estimate Cancer Incidence, Mortality and Prevalence Worldwide in 2012</description>
  </link>
  <reference>
    <citation>Jim HS, Andrykowski MA, Munster PN, Jacobsen PB. Physical symptoms/side effects during breast cancer treatment predict posttreatment distress. Ann Behav Med. 2007 Oct;34(2):200-8.</citation>
    <PMID>17927558</PMID>
  </reference>
  <reference>
    <citation>Manning-Walsh J. Social support as a mediator between symptom distress and quality of life in women with breast cancer. J Obstet Gynecol Neonatal Nurs. 2005 Jul-Aug;34(4):482-93.</citation>
    <PMID>16020416</PMID>
  </reference>
  <reference>
    <citation>Williams SA, Schreier AM. The effect of education in managing side effects in women receiving chemotherapy for treatment of breast cancer. Oncol Nurs Forum. 2004 Jan-Feb;31(1):E16-23.</citation>
    <PMID>14722602</PMID>
  </reference>
  <reference>
    <citation>Şahin ZA, Tan M. Quality of Life and Symptom Experience of Breast Cancer Patients Undergoing Chemotherapy. Holist Nurs Pract. 2016 Jul-Aug;30(4):193-200. doi: 10.1097/HNP.0000000000000157.</citation>
    <PMID>27309408</PMID>
  </reference>
  <reference>
    <citation>Deshields TL, Potter P, Olsen S, Liu J. The persistence of symptom burden: symptom experience and quality of life of cancer patients across one year. Support Care Cancer. 2014 Apr;22(4):1089-96. doi: 10.1007/s00520-013-2049-3. Epub 2013 Dec 3.</citation>
    <PMID>24292095</PMID>
  </reference>
  <reference>
    <citation>Roiland RA, Heidrich SM. Symptom clusters and quality of life in older adult breast cancer survivors. Oncol Nurs Forum. 2011 Nov;38(6):672-80. doi: 10.1188/11.ONF.672-680.</citation>
    <PMID>22037330</PMID>
  </reference>
  <reference>
    <citation>Liang SY, Chao TC, Tseng LM, Tsay SL, Lin KC, Tung HH. Symptom-Management Self-efficacy Mediates the Effects of Symptom Distress on the Quality of Life Among Taiwanese Oncology Outpatients With Breast Cancer. Cancer Nurs. 2016 Jan-Feb;39(1):67-73. doi: 10.1097/NCC.0000000000000244.</citation>
    <PMID>25730592</PMID>
  </reference>
  <reference>
    <citation>Wu HS, Harden JK. Symptom burden and quality of life in survivorship: a review of the literature. Cancer Nurs. 2015 Jan-Feb;38(1):E29-54. doi: 10.1097/NCC.0000000000000135. Review.</citation>
    <PMID>24831042</PMID>
  </reference>
  <reference>
    <citation>Reed E, Kössler I, Hawthorn J. Quality of life assessments in advanced breast cancer: should there be more consistency? Eur J Cancer Care (Engl). 2012 Sep;21(5):565-80. doi: 10.1111/j.1365-2354.2012.01370.x. Epub 2012 Jun 4. Review.</citation>
    <PMID>22672416</PMID>
  </reference>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 29, 2017</study_first_submitted>
  <study_first_submitted_qc>April 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 10, 2017</study_first_posted>
  <last_update_submitted>April 7, 2017</last_update_submitted>
  <last_update_submitted_qc>April 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chulabhorn Cancer Center</investigator_affiliation>
    <investigator_full_name>Saengrawee Thanthong</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

